Literature DB >> 25714545

The miRNA-Kallikrein interactions: adding a new dimension.

Maria D Pasic1, Georgia Sotiropoulou, George M Yousef.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25714545      PMCID： PMC4418286          DOI： 10.1080/15384101.2015.1006541

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.

Authors:  Sara Samaan; Zsuzsanna Lichner; Qiang Ding; Carol Saleh; Joseph Samuel; Catherine Streutker; George M Yousef
Journal:  Biol Chem       Date:  2014-09       Impact factor: 3.915

Review 2.  Human tissue kallikreins: from gene structure to function and clinical applications.

Authors:  George M Yousef; Christina V Obiezu; Liu-Ying Luo; Angeliki Magklara; Carla A Borgoño; Tadaaki Kishi; Nader Memari; lacovos P Michael; Michael Sidiropoulos; Lisa Kurlender; Katerina Economopolou; Carl Kapadia; Nahoko Komatsu; Constantina Petraki; Marc Elliott; Andreas Scorilas; Dionyssios Katsaros; Michael A Levesque; Eleftherios P Diamandis
Journal:  Adv Clin Chem       Date:  2005       Impact factor: 5.394

Review 3.  Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.

Authors:  Maria D Pasic; Ekaterina Olkhov; Bharati Bapat; George M Yousef
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

4.  A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

Authors:  Leonardo Salmena; Laura Poliseno; Yvonne Tay; Lev Kats; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-07-28       Impact factor: 41.582

Review 5.  Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.

Authors:  J Dorn; J Bayani; G M Yousef; F Yang; V Magdolen; M Kiechle; E P Diamandis; M Schmitt
Journal:  Thromb Haemost       Date:  2013-06-13       Impact factor: 5.249

Review 6.  Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases.

Authors:  Jyotsna Batra; Tracy O'Mara; Radhika Patnala; Felicity Lose; Judith A Clements
Journal:  Biol Chem       Date:  2012-12       Impact factor: 3.915

7.  Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.

Authors:  Konstantinos G Sidiropoulos; Nicole M A White; Anna Bui; Qiang Ding; Peter Boulos; Georgios Pampalakis; Heba Khella; Joseph N Samuel; Georgia Sotiropoulou; George M Yousef
Journal:  Oncoscience       Date:  2014-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.